|
Characteristics
|
HF patients (n = 7)
|
Non-HF patients (n = 7)
|
P
value
|
|---|
|
Men
|
7 (100%)
|
7 (100%)
|
NA
|
|
Women
|
0 (0%)
|
0 (0%)
|
NA
|
|
Age (years)
|
59.7 ± 9.4
|
56.7 ± 13.2
|
0.634
|
|
BMI (kg/m2)
|
30 ± 3.7
|
26.1 ± 4.2
|
0.092
|
|
Hypertension
|
5 (71.4%)
|
5 (71.4%)
|
1
|
|
Diabetes
|
2 (28.6%)
|
0 (0%)
|
0.462
|
|
Previous MI
|
0 (0%)
|
0 (0%)
|
NA
|
|
Smoking
|
3 (42.9%)
|
5 (71.4%)
|
0.592
|
|
Hypercholesterolemia
|
5 (71.4%)
|
5 (71.4%)
|
1
|
|
AMI
|
3 (42.9%)
|
2 (28.6%)
|
1
|
|
NT-proBNP (pg/mL)a
|
1,960.9 ± 3,421.9
|
119.4 ± 118.9
|
0.002
|
|
LVEF (%)a
|
28.9 ± 6.3
|
57.7 ± 4.7
|
<0.001
|
|
Medications
|
|
Aspirin
|
7 (100%)
|
7 (100%)
|
NA
|
|
Clopidogrel
|
7 (100%)
|
7 (100%)
|
NA
|
|
Beta blockers
|
7 (100%)
|
6 (85.7%)
|
1
|
|
ACE inhibitors
|
7 (100%)
|
7 (100%)
|
NA
|
|
Statins
|
7 (100%)
|
7 (100%)
|
NA
|
|
Diuretics
|
5 (71.4%)
|
1 (14.3%)
|
0.103
|
-
aNT-proBNP, LVEF measured 6 months after AMI.
- Data are presented as mean value ± standard deviation or number or percentage of patients. P value <0.05 was considered significant.
- ACE, angiotensin-converting enzyme; AMI, anterior myocardial infarction; BMI, body mass index; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NA, not applicable; NT-proBNP, N-terminal pro-brain natriuretic peptide.
